AMNEAL PHARMACEUTICALS OF NEW YORK H-1B Visa Sponsorship & Salary Data

The median H-1B salary at AMNEAL PHARMACEUTICALS OF NEW YORK is $105,928, based on 50 certified filings from FY 2020 to FY 2026. This is 12% lower than the national H-1B median salary of $120,000. Compensation at AMNEAL PHARMACEUTICALS OF NEW YORK reflects their market positioning, with entry-level roles starting around $85,000 and senior positions reaching $190,420 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at AMNEAL PHARMACEUTICALS OF NEW YORK range from $76,814 at the 10th percentile to $190,420 at the 90th percentile, showing a $113,606 spread across experience levels and roles. The 25th percentile is $85,000 and the 75th percentile is $143,742.

Yes, AMNEAL PHARMACEUTICALS OF NEW YORK actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 50 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 50 certified applications and a 0% denial rate, AMNEAL PHARMACEUTICALS OF NEW YORK maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), AMNEAL PHARMACEUTICALS OF NEW YORK filed 1 H-1B applications, with 1 certified and 0 denied. Over 7 years of data, AMNEAL PHARMACEUTICALS OF NEW YORK has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

AMNEAL PHARMACEUTICALS OF NEW YORK's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 50 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating AMNEAL PHARMACEUTICALS OF NEW YORK as a potential H-1B sponsor.

This is an excellent approval rate, indicating AMNEAL PHARMACEUTICALS OF NEW YORK has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

AMNEAL PHARMACEUTICALS OF NEW YORK sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 50 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles AMNEAL PHARMACEUTICALS OF NEW YORK most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at AMNEAL PHARMACEUTICALS OF NEW YORK:

The most frequently sponsored role is Research Scientist III with 6 filings at a median salary of $119,269. This is followed by Research Scientist (4 filings) and Associate Research Scientist.

AMNEAL PHARMACEUTICALS OF NEW YORK's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where AMNEAL PHARMACEUTICALS OF NEW YORK sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top AMNEAL PHARMACEUTICALS OF NEW YORK H-1B locations:

The largest H-1B hub for AMNEAL PHARMACEUTICALS OF NEW YORK is Brookhaven, NY with 49 filings at a median salary of $105,928. The highest-paying location is Brookhaven, NY at $105,928 median. Salaries range from $94,765 to $105,928 across office locations.

AMNEAL PHARMACEUTICALS OF NEW YORK's median H-1B salary has increased by +101% from FY 2020 ($94,744) to FY 2026 ($190,000). Tracking salary trends over time reveals how AMNEAL PHARMACEUTICALS OF NEW YORK adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at AMNEAL PHARMACEUTICALS OF NEW YORK.

Year-by-year breakdown:

• FY 2022: $119,269 (7 certified)
• FY 2023: $222,578 (2 certified)
• FY 2024: $130,000 (4 certified)
• FY 2025: $104,149 (19 certified)
• FY 2026: $190,000 (1 certified)

This 101% growth reflects strong compensation adjustments at AMNEAL PHARMACEUTICALS OF NEW YORK, keeping pace with market demands for H-1B talent.

AMNEAL PHARMACEUTICALS OF NEW YORK primarily files H-1B applications at Wage Level II, accounting for 30% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making AMNEAL PHARMACEUTICALS OF NEW YORK's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 82% of positions at Level II or higher, AMNEAL PHARMACEUTICALS OF NEW YORK typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

AMNEAL PHARMACEUTICALS OF NEW YORK's median H-1B salary of $105,928 is 12% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating AMNEAL PHARMACEUTICALS OF NEW YORK's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare AMNEAL PHARMACEUTICALS OF NEW YORK's offerings with similar companies in your field for a more accurate assessment.

AMNEAL PHARMACEUTICALS OF NEW YORK's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. AMNEAL PHARMACEUTICALS OF NEW YORK's higher proportion of Level III-IV positions (52%) may benefit from wage-based lottery prioritization.

With 50 certified filings, AMNEAL PHARMACEUTICALS OF NEW YORK invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.